InvestorsHub Logo
Followers 253
Posts 17905
Boards Moderated 0
Alias Born 01/19/2006

Re: ziploc_1 post# 421105

Friday, 02/02/2024 3:04:22 PM

Friday, February 02, 2024 3:04:22 PM

Post# of 423967
I read your quote. Dr Gottlieb was on CNBC-TV at 2:30 pm today, discussing LLY and NVO pipelines and additional advantages/diseases to be obtained from treatments using respective weight loss drugs. Earlier, BMY/MRK patent cliffs were featured, with additional M/A activity discussed to diversify respective pipelines to treat additional diseases.

A good match between your quote and above discussion, IMO. Additional patent protection and reasonable M/A cost favor AMRN.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News